Changing The Way diseases are treated

Cancers / neural / Autoimmune diseases

We develop novel therapies for complicated diseases

through modulating multiple immune responses and signal pathways

MINC(Multi-target Immunotherapy NanoComplex) Technology

MINC(Multi-target Immunotherapy NanoComplex) Technology

-- A Multi-target-Immunotherapy Platform

SUNTEC is leveraging its proprietary MINC technology platform to develop Multi-target Immunotherapies with extraordinary . MINC drugs are unique in that they 1) can penetrate the BBB 2) modulate multiple immune/signaling pathways of disease for high efficacy and response rates, and 3) reduce drug toxicity.

Our strategy

MINC technology is a “new drug discovery platform” for multi-target immuno-biopharmaceuticals. Suntec focus in developing new biopharmaceuticals for cancer, central nervous system (CNS) and autoimmune (AI) diseases. MINC can also create new drugs to treat cardiovascular diseases (CVD), infectious diseases, gene therapies and vaccines.

Scroll to Top